Joshi Abhijeet R, Bobylev Ilja, Zhang Gang, Sheikh Kazim A, Lehmann Helmar C
Department of Neurology, University of Cologne, Germany; Center for Molecular Medicine Cologne, Cologne, Germany.
Department of Neurology, University of Texas Health Sciences Centre, Houston, TX, USA.
Exp Neurol. 2015 Jan;263:28-38. doi: 10.1016/j.expneurol.2014.09.012. Epub 2014 Sep 28.
The small GTPase RhoA and its down-stream effector Rho-kinase (ROCK) are important effector molecules of the neuronal cytoskeleton. Modulation of the RhoA/ROCK pathway has been shown to promote axonal regeneration, however in vitro and animal studies are inconsistent regarding the extent of axonal outgrowth induced by pharmacological inhibition of ROCK. We hypothesized that injury to sensory and motor nerves result in diverse activation levels of RhoA, which may impact the response of those nerve fiber modalities to ROCK inhibition. We therefore examined the effects of Y-27632, a chemical ROCK inhibitor, on the axonal outgrowth of peripheral sensory and motor neurons grown in the presence of growth-inhibiting chondroitin sulfate proteoglycans (CSPGs). In addition we examined the effects of three different doses of Y-27632 on nerve regeneration of motor and sensory nerves in animal models of peripheral nerve crush. In vitro, sensory neurons were less responsive to Y-27632 compared to motor neurons in a non-growth permissive environment. These differences were associated with altered expression and activation of RhoA in sensory and motor axons. In vivo, systemic treatment with high doses of Y-27632 significantly enhanced the regeneration of motor axons over short distances, while the regeneration of sensory fibers remained largely unchanged. Our results support the concept that in a growth non-permissive environment, the regenerative capacity of sensory and motor axons is differentially affected by the RhoA/ROCK pathway, with motor neurons being more responsive compared to sensory. Future treatments, that are aimed to modulate RhoA activity, should consider this functional diversity.
小GTP酶RhoA及其下游效应分子Rho激酶(ROCK)是神经元细胞骨架的重要效应分子。已表明调节RhoA/ROCK信号通路可促进轴突再生,然而,关于ROCK药理抑制诱导的轴突生长程度,体外和动物研究结果并不一致。我们推测,感觉神经和运动神经损伤会导致RhoA的激活水平不同,这可能会影响这些神经纤维模式对ROCK抑制的反应。因此,我们研究了化学ROCK抑制剂Y-27632对在存在生长抑制性硫酸软骨素蛋白聚糖(CSPG)的情况下培养的外周感觉和运动神经元轴突生长的影响。此外,我们还研究了三种不同剂量的Y-27632对周围神经挤压动物模型中运动和感觉神经再生的影响。在体外,在非生长允许环境中,感觉神经元对Y-27632的反应比运动神经元弱。这些差异与感觉和运动轴突中RhoA的表达和激活改变有关。在体内,高剂量Y-27632的全身治疗显著增强了运动轴突在短距离内的再生,而感觉纤维的再生基本保持不变。我们的结果支持这样的概念,即在生长非允许环境中,感觉和运动轴突的再生能力受到RhoA/ROCK信号通路的不同影响,与感觉神经元相比,运动神经元的反应更强。未来旨在调节RhoA活性的治疗应考虑这种功能多样性。